(Q41021450)

25 September 2017

Antisense phosphorothioate oligodeoxynucleotide down-regulation of the insulin-like growth factor I receptor in ovarian cancer cells (English)

1 reference

25 September 2017

1 reference

M Müller

1

1 reference

25 September 2017

M Dietel

series ordinal

2

1 reference

25 September 2017

A Turzynski

series ordinal

3

1 reference

25 September 2017

K Wiechen

series ordinal

4

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 August 1998

1 reference

International Journal of Cancer

25 September 2017

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

25 September 2017

77

1 reference

25 September 2017

4

1 reference

25 September 2017

567-571

1 reference

Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo

25 September 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980812%2977%3A4%3C567%3A%3AAID-IJC16%3E3.0.CO%3B2-3

A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980812%2977%3A4%3C567%3A%3AAID-IJC16%3E3.0.CO%3B2-3

Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980812%2977%3A4%3C567%3A%3AAID-IJC16%3E3.0.CO%3B2-3

Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980812%2977%3A4%3C567%3A%3AAID-IJC16%3E3.0.CO%3B2-3

Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980812%2977%3A4%3C567%3A%3AAID-IJC16%3E3.0.CO%3B2-3

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980812%2977%3A4%3C567%3A%3AAID-IJC16%3E3.0.CO%3B2-3

Antisense DNA downregulation of the ERBB2 oncogene measured by a flow cytometric assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980812%2977%3A4%3C567%3A%3AAID-IJC16%3E3.0.CO%3B2-3

Gene inhibition using antisense oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980812%2977%3A4%3C567%3A%3AAID-IJC16%3E3.0.CO%3B2-3

Physiological role of the insulin-like growth factor binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980812%2977%3A4%3C567%3A%3AAID-IJC16%3E3.0.CO%3B2-3

10.1002/(SICI)1097-0215(19980812)77:4<567::AID-IJC16>3.0.CO;2-3

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference